Nonsurgical Skin Cancer Treatment Reaches 150,000 Patient Milestone

Martini’s journey began after a routine biopsy on her nose. Her initial provider recommended Mohs surgery, a procedure that would have required a four-hour commute and potentially left a significant scar near her eye. When she discovered that Dr. Janine Hopkins offered Image-Guided Superficial Radiation Therapy (IGSRT) in her hometown of Monroe, she felt misled by her previous doctor, who had failed to mention the nonsurgical alternative.

Dr. Hopkins, a dermatologist with three decades of experience, explained that the GentleCure protocol achieves a 99% cure rate, matching traditional surgery without the need for cutting or reconstruction. For the patient, the treatment involved a series of 15-minute sessions that allowed her to maintain her daily routine. Following the final session, high-resolution ultrasound confirmed the cancer was cleared, leaving only a minor mark from the original biopsy.

SkinCure Oncology, the company behind the treatment model, now partners with roughly 500 physicians across the country. CEO Kerwin Brandt advocates for greater transparency in dermatology, urging practitioners to provide patients with all available options for early-stage nonmelanoma skin cancer. Martini hopes her experience prompts others to conduct independent research before committing to invasive procedures.